animal drug

• 動物用医薬品

関

veterinary drug

WordNet

1. a living organism characterized by voluntary movement (同)animate being, beast, brute, creature, fauna
2. marked by the appetites and passions of the body; "animal instincts"; "carnal knowledge"; "fleshly desire"; "a sensual delight in eating"; "music is the only sensual pleasure without vice" (同)carnal, fleshly, sensual
3. use recreational drugs (同)do drugs
4. administer a drug to; "They drugged the kidnapped tourist" (同)dose
5. a substance that is used as a medicine or narcotic
6. (Jungian psychology) the inner self (not the external persona) that is in touch with the unconscious

PrepTutorEJDIC

1. (植物に対して)『動物』 / (人間以外の)『動物』,けだもの / (魚・鳥などに対して)哺乳動物(mammal) / けだもの(野獣)のような人 / (比較変化なし)《名詞の前にのみ用いて》動物の,動物性の,動物質の / (知的・精神的に対して)動物的な;肉欲的な
2. 『薬』,薬品,薬剤 / 『麻薬』,麻酔剤 / 〈人〉‘に'薬(特に麻酔剤)を与える / 〈飲食物〉‘に'(麻酔薬・毒薬などの)薬を混ぜる

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/08/12 09:18:50」(JST)

wiki en

[Wiki en表示]

A veterinary drug (also animal drug) refers to a drug intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals.

Regulation

United States

The U.S. Food and Drug Administration (FDA) has the broad mandate under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321 et seq.) to assure the safety and effectiveness of animal drugs and their use in all animals, including farm animals. Before FDA formally approves an animal drug, the sponsor or manufacturer of the drug must document in scientific testing that the drug has been found "safe and effective". The testing data also must demonstrate that a methodology is available to detect and measure any residue left in edible animal products. Farmers and veterinarians using drugs on farm animals must adhere to guidelines about how much time must elapse before a treated animal can be slaughtered, and any other use constraints or warnings stated on the drug label. Animal biologics (e.g., vaccines and tests) are regulated by the Animal and Plant Health Inspection Service.

See also

• List of veterinary drugs
• Veterinary medicine
• Veterinary pathology

References

•  This article incorporates public domain material from the Congressional Research Service document "Report for Congress: Agriculture: A Glossary of Terms, Programs, and Laws, 2005 Edition" by Jasper Womach.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. アルコールおよびその他の薬物の有害な使用のスクリーニング screening for unhealthy use of alcohol and other drugs
• 2. I群抗不整脈薬の主な副作用 major side effects of class i antiarrhythmic drugs
• 3. リウマチ性疾患を有する男性における抗炎症剤および免疫抑制剤が性腺機能に及ぼす影響 effects of antiinflammatory and immunosuppressive drugs on gonadal function in men with rheumatic diseases
• 4. 統合失調症に対する薬物療法：持効性抗精神病薬注射製剤 pharmacotherapy for schizophrenia long acting injectable antipsychotic drugs
• 5. 妊娠中および授乳中のリウマチ性疾患における抗炎症剤および免疫抑制剤の使用 use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation

English Journal

• Tumor-colonizing bacteria: A potential tumor targeting therapy.

• Zu C, Wang J.Author information Department of Oncosurgery, First Affiliated Hospital of Medical School, Xi'an Jiaotong University , Xi'an , China.AbstractAbstract In 1813, Vautier published his observation of tumor regression in patients who had suffered from gas gangrene. Since then, many publications have described the use of bacteria as antitumor therapy. For example, Bifidobacterium and Clostridium have been shown to selectively colonize tumors and to reduce tumor size. In addition, recent studies have focused on the use of genetic engineering to induce the expression of pro-drug converting enzymes, cytokines, specific antibodies, or suicide genes in tumor-colonizing bacteria. Moreover, some animal experiments have reported the treatment of tumors with engineered bacteria, and few side effects were observed. Therefore, based on these advances in tumor targeting therapy, bacteria may represent the next generation of cancer therapy.
• Critical reviews in microbiology.Crit Rev Microbiol.2014 Aug;40(3):225-35. doi: 10.3109/1040841X.2013.776511. Epub 2013 Aug 22.
• Abstract In 1813, Vautier published his observation of tumor regression in patients who had suffered from gas gangrene. Since then, many publications have described the use of bacteria as antitumor therapy. For example, Bifidobacterium and Clostridium have been shown to selectively colonize tumors a
• PMID 23964706

• Mometasone furoate hydrogel for scalp use: in vitro and in vivo evaluation.

• Salgado A, Raposo S, Marto J, Silva AN, Simões S, Ribeiro HM.Author information Laboratório de Tecnologia Farmacêutica, Faculdade de Farmácia, iMed.UL - Research Institute for Medicines and Pharmaceutical Sciences, Universidade de Lisboa , Lisboa , Portugal.AbstractAbstract Dermatological inflammatory diseases often affect the scalp and the eyebrows. Common dosage forms available on the market for those situations are lotions; however, the presence of hair limits their use. Gels, for their consistency and adhesiveness, are a suitable alternative to the lotions in these situations. The aim of this study was to develop a new stable gel containing mometasone furoate (MF), with anti-inflammatory activity and a controlled delivery, to improve topical treatment of scalp dermatitis. Pharmaceutical development, physical and chemical characterization, stability, in vitro release and permeation studies and in vivo anti-inflammatory activity were performed. The gel presented an acidic pH and an apparent viscosity of 35 Pa.s. The microbiological analysis showed that the results were within the established specification limits. The release and the permeation profiles suggest that the drug is mainly retained in the upper skin layers. MF gel was tested in an animal model of cutaneous inflammation and presented similar anti-inflammatory activity compared to a commercially available MF dosage form. The gel was chemically, physically and microbiologically stable. The results suggest that the developed hydrogel formulation containing MF can be of actual value for improving the clinical effectiveness in the treatment of scalp dermatitis.
• Pharmaceutical development and technology.Pharm Dev Technol.2014 Aug;19(5):618-22. doi: 10.3109/10837450.2013.819012. Epub 2013 Jul 22.
• Abstract Dermatological inflammatory diseases often affect the scalp and the eyebrows. Common dosage forms available on the market for those situations are lotions; however, the presence of hair limits their use. Gels, for their consistency and adhesiveness, are a suitable alternative to the lotions
• PMID 23869426

• Collagen loaded nano-sized surfactant based dispersion for topical application: formulation development, characterization and safety study.

• Ahmad I, Akhter S, Ahmad MZ, Shamim M, Rizvi MA, Khar RK, Ahmad FJ.Author information Nanoformulation Research Lab., Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard (Hamdard University) , New Delhi , India .AbstractAbstract Collagen, a high molecular weight, hydrophilic and highly abundant protein is known to have anti-ageing, anti-wrinkle, anti-acne, anti-scar and wound healing properties. High molecular weight and hydrophilic nature hinder its effective topical delivery. So, the objective of present study was to develop effective topical nano-surfactant dispersion (NSD) for collagen delivery. NSD was prepared from sorbitan monostearate (Span60) and cholesterol using ethanol injection method followed by probe sonication. NSD was characterized for entrapment efficiency (%EE), size and size distribution (Z-avg and polydispersity index (PDI)), shape, zeta-potential (ζ), in vitro drug release, skin hydration and skin irritation test and histopathological examination. Optimized NSD (NSD3) had %EE, z-avg, PDI and ζ-potential of 77.56% ± 1.09%, 158.1 ± 2.31 nm, 0.211 and -17.2 ± 0.64 mV, respectively. In in vivo skin hydration test, NSD treatment showed nearly 2.5-fold and 3-fold increase in the thickness of stratum corneum (SC) as compared to the collagen gel treated and untreated skin, respectively. The mean scores of skin irritation test in two animal species, rats and rabbits, were found to be 1.42 ± 1.01 and 1.71 ± 0.29, respectively, indicating the non-irritant nature of collagen loaded NSD. Histopathology of the skin after application of developed NSD showed non-significant changes in skin anatomy indicating its safe nature.
• Pharmaceutical development and technology.Pharm Dev Technol.2014 Jun;19(4):460-7. doi: 10.3109/10837450.2013.795167. Epub 2013 May 15.
• Abstract Collagen, a high molecular weight, hydrophilic and highly abundant protein is known to have anti-ageing, anti-wrinkle, anti-acne, anti-scar and wound healing properties. High molecular weight and hydrophilic nature hinder its effective topical delivery. So, the objective of present study wa
• PMID 23675949

Japanese Journal

• Establishment of ATP-Based Luciferase Viability Assay in 96-Well Plate for Trypanosoma congolense

• Suganuma Keisuke,Allamanda Puttik,Hakimi Hassan,Zhou Mo,Angeles Jose Ma.,Kawazu Shin-ichiro,Inoue Noboru
• Journal of Veterinary Medical Science 76(11), 1437-1441, 2014-12-01
• … Animal African trypanosomosis (AAT), caused by Trypanosoma congolense, is widespread throughout sub-Saharan Africa. … Moreover, drug resistant trypanosomes have recently been reported in the field. … High throughput screening (HTS) of large chemical compound library collections is a promising approach for identifying novel drug candidates. …
• NAID 120005525307

• Parasitology : Establishment of ATP-Based Luciferase Viability Assay in 96-Well Plate for Trypanosoma congolense

• SUGANUMA Keisuke,ALLAMANDA Puttik,HAKIMI Hassan [他]
• The journal of veterinary medical science 76(11), 1437-1441, 2014-11
• NAID 40020277491

• 分子標的治療薬 (Clinical Consensus 右脳で理解する皮膚科診療 : 見えざる病態を診る(第6回)皮膚腫瘍・随伴する皮膚疾患)

• 大森 啓太郎
• Small animal
• NAID 40020273499

Related Links

• Animal & Veterinary - Food and Drug Administration

The United States federal agency that regulates the manufacture and distribution of food additives and drugs that will be given to animals. Includes antimicrobial resistance information, topical index, and agency information.

• Animal Drugs @ FDA - Accessdata FDA - Food and Drug ...

The FDA Approved Animal Drug Products, (Green Book), is published by the Drug Information Laboratory; paper copies are available by subscription.

Related Pictures

---

★リンクテーブル★

リンク元	「動物用医薬品」「veterinary drug」
関連記事	「animal」「drug」

「動物用医薬品」

　　[★]

英

veterinary drug、animal drug

関

動物薬

「veterinary drug」

　　[★]

• 動物用医薬品、動物薬

関

animal drug

「animal」

　　[★]

• n.

• 動物

• adj.

• 動物性の

関

Animalia、animality

　 　 　

「drug」

　　[★]

同

drugs